Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis

Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein with dual roles in redox signaling and programmed cell death. Deficiency in AIF is known to result in defective oxidative phosphorylation (OXPHOS), via loss of complex I activity and assembly in other tissues. Because the kidney relies on OXPHOS for metabolic homeostasis, we hypothesized that a decrease in AIF would result in chronic kidney disease (CKD). Here, we report that partial knockdown of Aif in mice recapitulates many features of CKD, in association with a compensatory increase in the mitochondrial ATP pool via a shift toward mitochondrial fusion, excess mitochondrial reactive oxygen species production, and Nox4 upregulation. However, despite a 50% lower AIF protein content in the kidney cortex, there was no loss of complex I activity or assembly. When diabetes was superimposed onto Aif knockdown, there were extensive changes in mitochondrial function and networking, which augmented the renal lesion. Studies in patients with diabetic nephropathy showed a decrease in AIF within the renal tubular compartment and lower AIFM1 renal cortical gene expression, which correlated with declining glomerular filtration rate. Lentiviral overexpression of Aif1m rescued glucose-induced disruption of mitochondrial respiration in human primary proximal tubule cells. These studies demonstrate that AIF deficiency is a risk factor for the development of diabetic kidney disease.

[1]  Y. Kanwar,et al.  Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  Kumar Sharma,et al.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.

[3]  R. Touyz,et al.  Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[4]  K. Tory,et al.  Activating HSP72 in Rodent Skeletal Muscle Increases Mitochondrial Number and Oxidative Capacity and Decreases Insulin Resistance , 2014, Diabetes.

[5]  V. D’Agati,et al.  Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. , 2014, The Journal of clinical investigation.

[6]  E. Rugarli,et al.  The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission , 2014, The Journal of cell biology.

[7]  S. McGee,et al.  Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action , 2014, Molecular metabolism.

[8]  A. Tobar,et al.  Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy , 2014, Journal of Lipid Research.

[9]  Songming Huang,et al.  Mitochondrial dysfunction in the pathophysiology of renal diseases. , 2014, American journal of physiology. Renal physiology.

[10]  T. Ideker,et al.  Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. , 2013, Journal of the American Society of Nephrology : JASN.

[11]  Y. Yoon,et al.  Mitochondrial morphology in metabolic diseases. , 2013, Antioxidants & redox signaling.

[12]  M. Cooper,et al.  Deficiency in mitochondrial complex I activity due to Ndufs6 gene trap insertion induces renal disease. , 2013, Antioxidants & redox signaling.

[13]  B. Westermann Bioenergetic role of mitochondrial fusion and fission. , 2012, Biochimica et biophysica acta.

[14]  P. Nicholls,et al.  Lentiviral transduction of rat Sertoli cells as a means to modify gene expression , 2012, Spermatogenesis.

[15]  W. Hsu,et al.  Transgenic Control of Mitochondrial Fission Induces Mitochondrial Uncoupling and Relieves Diabetic Oxidative Stress , 2012, Diabetes.

[16]  E. O'Neill,et al.  Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts. , 2012, Investigative ophthalmology & visual science.

[17]  P. Overbeek,et al.  Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. , 2012, Cell metabolism.

[18]  M. Knip,et al.  Advanced Glycation End Products Are Direct Modulators of β-Cell Function , 2011, Diabetes.

[19]  S. McGee,et al.  DHA Protects Against Zinc Mediated Alterations in Neuronal Cellular Bioenergetics , 2011, Cellular Physiology and Biochemistry.

[20]  I. Sevrioukova Apoptosis-inducing factor: structure, function, and redox regulation. , 2011, Antioxidants & redox signaling.

[21]  T. Dawson,et al.  Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos) , 2011, Science Signaling.

[22]  M. Knip,et al.  Advanced Glycation End Products Are Direct Modulators of b -Cell Function , 2011 .

[23]  R. Youle,et al.  Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells , 2010, The Journal of cell biology.

[24]  Benedikt Westermann,et al.  Mitochondrial fusion and fission in cell life and death , 2010, Nature Reviews Molecular Cell Biology.

[25]  T. Mak,et al.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.

[26]  P. Bénit,et al.  Life with or without AIF. , 2010, Trends in biochemical sciences.

[27]  M. Zeviani,et al.  Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. , 2010, American journal of human genetics.

[28]  Merlin C. Thomas,et al.  Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.

[29]  W. Sivitz,et al.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[30]  Z. Dong,et al.  Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. , 2009, The Journal of clinical investigation.

[31]  M. Cooper,et al.  RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. , 2009, Journal of the American Society of Nephrology : JASN.

[32]  A. Kribben,et al.  Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  P. Bénit,et al.  The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes , 2008, PloS one.

[34]  M. Cooper,et al.  Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes , 2008, Diabetes.

[35]  M. Cooper,et al.  Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.

[36]  R. Youle,et al.  OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. , 2008, Brain : a journal of neurology.

[37]  J. Bonventre,et al.  Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. , 2007, Journal of the American Society of Nephrology : JASN.

[38]  M. Lazarou,et al.  Analysis of mitochondrial subunit assembly into respiratory chain complexes using Blue Native polyacrylamide gel electrophoresis. , 2007, Analytical biochemistry.

[39]  R. Unwin,et al.  The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction , 2006, Nephron Physiology.

[40]  S. Fukuhara,et al.  Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure , 2006, Nephron Clinical Practice.

[41]  David S. Park,et al.  Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosis , 2006, The EMBO journal.

[42]  K. Mihara,et al.  Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space , 2005, The EMBO journal.

[43]  P. Bénit,et al.  AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.

[44]  C. Leeuwenburgh,et al.  Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[45]  P. Frachon,et al.  Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. , 2002, Molecular biology of the cell.

[46]  Wayne N. Frankel,et al.  The harlequin mouse mutation downregulates apoptosis-inducing factor , 2002, Nature.

[47]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[48]  H. Schägger Respiratory Chain Supercomplexes , 2001, IUBMB life.

[49]  G. Kroemer,et al.  NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.

[50]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[51]  R. Atkins,et al.  The enhancement of aminonucleoside nephrosis by the co-administration of protamine. , 1987, Kidney international.

[52]  S. Soltoff,et al.  ATP and the regulation of renal cell function. , 1986, Annual review of physiology.